Evidence map›Paper›PMID 31622530›Full record

ArticleBiotechnology progress2020

Mid-manufacturing storage: Antibody stability after chromatography and precipitation based capture steps.

Walpurga Krepper, Daniel Burgstaller, Alois Jungbauer, Peter Satzer

Abstract read
In one paragraph

Article in Biotechnology progress, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Walpurga KrepperDepartment of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.
Daniel BurgstallerDepartment of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.
Alois JungbauerDepartment of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.ORCID 0000-0001-8182-7728
Peter SatzerDepartment of Biotechnology, University of Natural Resources and Life Sciences, Vienna, Austria.

Funding

H2020 LEIT Biotechnology 635557
6 · The paper itself

Abstract

Antibodies of the IgG2 subclass were captured from the clarified cell culture fluid either by protein A chromatography or by polyethylene glycol precipitation. The captured intermediates were stored as neutralized eluates (protein A chromatography) or in solid form as polyethylene glycol precipitates over a period of 13 months at three temperatures, -20°C, 5°C, and room temperature to compare the capture technologies in regard of the resulting product storability. Monomer content, high molecular mass impurities product loss and changes in the composition of the charge variants were determined at six time points during the storage. At the beginning and end of the study, samples were additionally tested by differential scanning calorimetry, differential scanning fluorimetry, and circular dichroism to determine structural alterations occurring during storage. Protein A purified material was highly stable at all tested temperatures in regard of monomer content and product losses. A transient, acidic isoform was formed during the chromatography step which re-converted to the main charged variant upon storage within a matter of days. Precipitated antibodies could be stored at -20 or 5°C for 3 months without product losses but afterwards recovery yields dropped to 65%. At room temperature, the precipitated antibody was not stable and degraded within 3 months.

Indexed as

Calorimetry, Differential ScanningCircular DichroismImmunoglobulin GProtein ConformationProtein StabilityStaphylococcal Protein ATemperatureImmunoglobulin GStaphylococcal Protein Achromatographyimmunoglobulinprecipitationstorabilitystorage

Identifiers

PMID31622530
PMCPMC7187330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.